0
Skip to Content
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Launch of the Psychedelic Access and Research European Alliance

Next

Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality

You Might Also Like

Related Embedded Video Item Thumbnail Presentation of the results of ketamine-assisted therapy program for treatment resistant depression
Related Embedded Video Item Thumbnail Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023
Related Embedded Video Item Thumbnail The promise of psychedelic-assisted therapies
Related Embedded Video Item Thumbnail Tadeusz Hawrot PAREA: "Specificità e sinergie della ricerca terapeutica con psichedelici in Europa"
Related Embedded Video Item Thumbnail Ongoing trials investigating psychedelic-assisted therapies

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy